儿童支气管肺炎并发继发性血小板增多症的临床分析

doi:10.3760/cma.j.issn.1007-1245.2023.13.019

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (13): 1860-1863.DOI: 10.3760/cma.j.issn.1007-1245.2023.13.019

儿童支气管肺炎并发继发性血小板增多症的临床分析

侯俏珍何丽雅曹晓均韦晓燕曾华松

广州市妇女儿童医疗中心，广州　510000

收稿日期:2023-03-22 出版日期:2023-07-01 发布日期:2023-07-21
通讯作者: 曾华松，Email：yuexiuhqz@163.com

Clinical analysis of pediatric bronchopneumonia complicated by secondary thrombocytosis

Hou Qiaozhen, He Liya, Cao Xiaojun, Wei Xiaoyan, Zeng Huasong

Guangzhou Women and Children's Medical Center, Guangzhou 510000, China

Received:2023-03-22 Online:2023-07-01 Published:2023-07-21
Contact: Zeng Huasong, Email: yuexiuhqz@163.com

摘要/Abstract

摘要：

目的　通过分析儿童支气管肺炎并发继发性血小板增多症的临床资料，探讨肺炎儿童血小板增多的发病机制、影响因素、临床特征和意义，提高对继发性血小板增多症的认识。方法　选取2020年1月至2021年12月广州市妇女儿童医疗中心收治的支气管肺炎并发继发性血小板增多症77例，其中男48例，女性29例，年龄1个月～6岁。回顾性分析其临床资料，总结病原体、性别、年龄、治疗时间、血红蛋白、C反应蛋白、血小板特点等。结果　77例支气管肺炎并发继发性血小板增多症患儿中，最常见的病原体为腺病毒（11例）、呼吸道合胞病毒（10例）、支原体（7例）；血小板增多和重症肺炎的发生有相关性。结论　腺病毒、呼吸道合胞病毒、支原体在引起儿童肺炎并发继发性血小板增多症的机制方面具有一定的相关性。

关键词:

肺炎, 血小板增多, 呼吸道合胞病毒, 腺病毒, 支原体, 炎症因子

Abstract:

Objective　By analyzing clinical data from pediatric cases of bronchopneumonia complicated by secondary thrombocytosis, to explore the pathogenesis, influencing factors, clinical characteristics, and significance of secondary thrombocytosis in children with pneumonia, and to enhance the understanding of secondary thrombocytosis. Methods　A total of 77 cases of thrombocytosis secondary to bronchopneumonia admitted to Guangzhou Women and Children's Medical Center between January 2020 and December 2021 were selected for retrospective analysis, including 48 boys and 29 girls, aged from 1 month to 6 years. The clinical data were analyzed to summarize the pathogens, gender, age, treatment duration, hemoglobin, C-reactive protein, and platelet characteristics. Results　Among the 77 children with thrombocytosis secondary to bronchopneumonia, the most common pathogens identified were adenovirus (11 cases), respiratory syncytial virus (10 cases), and mycoplasma (7 cases); there was relevance between thrombocytosis and severe pneumonia. Conclusion　Adenovirus, respiratory syncytial virus, and mycoplasma have some relevance in the mechanism of causing secondary thrombocytosis in children with bronchopneumonia.

Key words:

Pneumonia, Thrombocytosis, Respiratory syncytial virus, Adenovirus, Mycoplasma, Inflammatory factors

侯俏珍何丽雅曹晓均韦晓燕曾华松.

儿童支气管肺炎并发继发性血小板增多症的临床分析 [J]. 国际医药卫生导报, 2023, 29(13): 1860-1863.

Hou Qiaozhen, He Liya, Cao Xiaojun, Wei Xiaoyan, Zeng Huasong.

Clinical analysis of pediatric bronchopneumonia complicated by secondary thrombocytosis [J]. International Medicine and Health Guidance News, 2023, 29(13): 1860-1863.

参考文献

[1] 文飞球,刘四喜.儿童血小板增多症[J].中华实用儿科临床杂志,2013,28(15):1124-1125. DOI:10.3760/cma.j.issn.2095-428X.2013.15.002.
[2] 中华医学会儿科学分会呼吸学组,«中华儿科杂志»编辑委员会.儿童社区获得性肺炎管理指南(2013修订)(上)[J].中华儿科杂志,2013,51(10):745-752. DOI:10.3760/cma.j.issn.0578-1310.2013.10.006.
[3] Chiarello P, Magnolia M, Rubino M, et al. Thrombocytosis in children[J]. Minerva Pediatr, 2011, 63(6):507-513.
[4] Cheminant M, Delarue R. Investigation and management of patients presenting with thrombocytosis[J]. Rev Med Interne, 2013, 34(8):465-471. DOI: 10.1016/j.revmed. 2013.02.020.
[5] Kanikarla Marie P, Fowlkes NW, Afshar-Kharghan V, et al. The provocative roles of platelets in liver disease and cancer[J]. Front Oncol, 2021, 11:643815. DOI: 10.3389/fonc.2021.643815.
[6] Varon D, Shai E. Platelets and their microparticles as key players in pathophysiological responses[J]. J Thromb Haemost, 2015, 13 Suppl 1:S40-S46. DOI: 10.1111/jth.12976.
[7] Carestia A, Godin LC, Jenne CN. Step up to the platelet: role of platelets in inflammation and infection[J]. Thromb Res, 2022:S0049-3848(22)00411-X. DOI: 10.1016/j.thromres.2022.10.001.
[8] Thomas MR, Storey RF. The role of platelets in inflammation[J]. Thromb Haemost, 2015, 114(3):449-458. DOI: 10.1160/TH14-12-1067.
[9] Rondina MT, Garraud O. Emerging evidence for platelets as immune and inflammatory effector cells[J]. Front Immunol, 2014, 5:653. DOI: 10.3389/fimmu.2014.00653.
[10] 任晓旭.重症腺病毒感染对血液系统的损伤[J].中国小儿急救医学,2019,26(10):729-733. DOI:10.3760/cma.j.issn.1673-4912.2019.10.003.
[11] 国家呼吸系统疾病临床医学研究中心,中华医学会儿科学分会呼吸学组,中国医师协会呼吸医师分会儿科呼吸工作委员会,等.儿童呼吸道合胞病毒感染诊断、治疗和预防专家共识[J].中华实用儿科临床杂志,2020,35(4):241-250. DOI:10.3760/cma.j.cn101070-20200225-00243.
[12] 中华医学会儿科学分会呼吸学组,«中华实用儿科临床杂志»编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304-1308. DOI:10.3760/cma.j.issn.2095- 428X.2015.17.006.
[13] 李琳霞,赵琳,李艳红,等.新生儿感染性肺炎血小板参数的动态变化[J].中国新生儿科杂志,2010,25(3):172-173. DOI:10.3969/j.issn.1673-6710.2010.03.017.
[14] 廖景文.肺炎婴儿危重病例评分与血小板数量关系探讨[J].中国中西医结合儿科学,2015,7(6):572-574. DOI:10.3969/j.issn.1674-3865.2015.06.013.
[15] 张向峰,常会娟,张小宁,等.小儿支气管肺炎伴血小板增多的临床特征及炎症因子的变化情况分析[J].中国实用医刊,2017,44(7):90-92. DOI:10.3760/cma.j.issn.1674-4756. 2017.07.029.
[16] 刘蕾,许婉华,周丽霞,等.血小板生成素水平在急性炎症状态的变化及其意义探讨[J].中国实验血液学杂志,2017,25(3):860-865. DOI:10.7534/j.issn.1009-2137.2017. 03.041.
[17] Xiang M, Wu X, Jing H, et al. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors[J]. Front Immunol, 2022, 13:955654. DOI: 10.3389/fimmu.2022.955654.
[18] Granja TF, Köhler D, Leiss V, et al. Platelets and the cybernetic regulation of ischemic inflammatory responses through PNC formation regulated by extracellular nucleotide metabolism and signaling[J]. Cells, 2022, 11(19):3009. DOI: 10.3390/cells11193009.
[19] Yadav P, Beura SK, Panigrahi AR, et al. Platelet-derived microvesicles activate human platelets via intracellular calcium mediated reactive oxygen species release[J]. Blood Cells Mol Dis, 2023, 98:102701. DOI: 10.1016/j.bcmd.2022.102701.
[20] Marr N, Wang TI, Kam SH, et al. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children[J]. J Immunol, 2014, 192(3):948-957. DOI: 10.4049/jimmunol.1302007.

儿童支气管肺炎并发继发性血小板增多症的临床分析

Clinical analysis of pediatric bronchopneumonia complicated by secondary thrombocytosis

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics